Education
About Us
Working with TipRanks
Follow Us
Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -235.25K | C$ -209.91K | C$ -193.27K | C$ -111.53K | C$ -116.81K |
| Operating Income | C$ -36.99M | C$ -36.90M | C$ -22.63M | C$ -20.87M | C$ -2.25M |
| EBITDA | C$ -33.72M | C$ -37.40M | C$ -22.14M | C$ -21.96M | C$ -2.01M |
| Net Income | C$ -34.94M | C$ -37.39M | C$ -23.26M | C$ -22.99M | C$ -4.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 33.10M | C$ 19.34M | C$ 24.74M | C$ 29.90M | C$ 150.13K |
| Total Assets | C$ 34.94M | C$ 26.72M | C$ 25.88M | C$ 31.22M | C$ 1.45M |
| Total Debt | C$ 71.86K | C$ 10.45M | C$ 10.55M | C$ 9.56M | C$ 12.77M |
| Net Debt | C$ -33.03M | C$ -11.72M | C$ -14.19M | C$ -11.34M | C$ 12.62M |
| Total Liabilities | C$ 4.46M | C$ 25.55M | C$ 14.51M | C$ 11.67M | C$ 23.12M |
| Stockholders' Equity | C$ 33.40M | C$ 2.22M | C$ 12.86M | C$ 20.39M | C$ -21.21M |
| Cash Flow | |||||
| Free Cash Flow | C$ -30.10M | C$ -28.02M | C$ -19.08M | C$ -15.07M | C$ -403.93K |
| Operating Cash Flow | C$ -29.99M | C$ -27.92M | C$ -18.78M | C$ -14.64M | C$ -403.93K |
| Investing Cash Flow | C$ -75.16K | C$ -99.03K | C$ 8.70M | C$ -14.45M | C$ 24.62K |
| Financing Cash Flow | C$ 45.78M | C$ 27.84M | C$ 13.52M | C$ 49.92M | C$ -626.64K |